Laryngeal Mask Airway Versus Air Q Laryngeal Airway

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-01

Study Completion Date

2019-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nowadays, supraglottic airway devices are simple and effective alternatives to endotracheal intubation. Both laryngeal mask airway LMA and air-Q airway are supraglottic airway devices that can be used to maintain and protect airways from aspiration of secretions and blood during DCR surgery. The present study was designed to compare standard LMA versus air Q as regards the sealing effect and aspiration of blood in DCR surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ventilation With Supraglottic Airway Devices

NCT04421261

Laryngeal Masks Comparison

COMPLETED

Safety and Limitation of the 2nd Generation Laryngeal Mask Airway in the Lithotomy Position: An Obsevational Study

NCT05920447

Airway Management

COMPLETED

Blind Tracheal Intubation Through Supraglottic Airway Devices

NCT05624073

Respiration and the Airways With Laryngeal Masks

UNKNOWN

Respiration and The Airway With Supraglottic Airway Devices

NCT03384056

Laryngeal Masks Comparison

COMPLETED

Air-Q in Totally Edentulous and Dentate Geriatric Patients

NCT07138079

Postoperative Complications Sore-throat

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

72 patients were divided into two groups, 36 patients each, named LMA group, and air Q group according to supraglottic devices used. The following parameters were recorded in both studied groups, continuous Electrocardiography (ECG), heart rate (HR), means arterial pressure (MAP), arterial oxygen saturation (SpO2), end tidal carbon di-oxide (PCO2)..Oro pharyngeal leak pressure in (cmH2O), exhaled tidal volume in (ml), leak volume in (ml), leak fraction in (%) number of shifting from LMA to air Q or ETT and shifting from air Q to LMA or ETT was recorded with absence or presence of surgical blood on The undersurface of the device used.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Airway Devices

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel assignment

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Participiant Investigator

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LMA

36 patients were ventilated with LMA during dacryocystorhinostomy surgery

Group Type ACTIVE_COMPARATOR

LMA group

Intervention Type DEVICE

patients were ventilated with LMA

AirQ

36 patients each were ventilated with air Q airway during dacryocystorhinostomy surgery

Group Type ACTIVE_COMPARATOR

AirQ group

Intervention Type DEVICE

patients were ventilated with AirQ airway

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LMA group

patients were ventilated with LMA

Intervention Type DEVICE

AirQ group

patients were ventilated with AirQ airway

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both sex
* Age: 18-60 years
* ASA I-II
* Patients scheduled for dacryocystorhinostomy surgery

Exclusion Criteria

* Any pathology of the neck, upper respiratory tract, upper alimentary tract
* Patients with a history of gastric regurgitation, heartburn
* Morbid obese,
* Patients with esophageal reflux (hiatus hernia)
* Anticipating difficult airway management
* Patients with coagulation disorders

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes